Nov. 22—23andMe has detailed its plans for Bay Area job cuts, while separate tech company cutbacks have helped to shove the technology industry's current burst of layoffs past the 49,000 mark in the ...

Research indicates that dilated cardiomyopathy can be caused by the cumulative influence of potentially thousands of genes, not just one single genetic variant.

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

The facility intends to promote on-site collaboration, co-development, and learning with clients and external innovation ...

Spread the loveThe Durham–Chapel Hill metro area, part of North Carolina’s Research Triangle, is experiencing an unprecedented boom in its biotechnology and life sciences sectors. The region has ...

Biotech startup Enveda has raised a $130 million Series C, the Colorado company said Thursday morning.

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...

Novartis has acquired Kate Therapeutics for up to $1.1 billion, the companies said today, in a deal that expands the buyer’s ...

Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Genmab's Anthony Pagano sat down with Fierce Biotech at the Jefferies conference in London to talk M&A, asset ownership and ...

The genomic medicine space has seen incredible success, but investors are overlooking it. For once, it’s not efficacy that’s ...

Many biopharma professionals view smaller companies as having the best flexibility and remote work options, but that doesn’t ...